FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France
NCT03884413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 517
Last updated 2025-08-11
Summary
FErtility, PrEgnancy, contRaceptIon after breast Cancer in France
Conditions
- Breast Cancer Female
Interventions
- OTHER
-
questionnaires
Longitudinal observational study. Collection of health data using self-administered questionnaires online.
Sponsors & Collaborators
-
seintinelles network
collaborator UNKNOWN -
Institut Curie
lead OTHER
Principal Investigators
-
Anne-Sophie HAMY-PETIT, MD · Institut Curie
Eligibility
- Min Age
- 18 Years
- Max Age
- 43 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-08
- Primary Completion
- 2021-03-08
- Completion
- 2022-03-08
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT01459003 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Locoregional Recurrence of Breast Cancer
NCT05988112 ·Status: NOT_YET_RECRUITING
-
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 ·Status: COMPLETED
-
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
NCT05981326 ·Status: RECRUITING ·Phase: NA
-
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT03729115 ·Status: RECRUITING ·Phase: NA
-
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750 ·Status: COMPLETED
-
Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer
NCT01349842 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
NCT03422003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
NCT05772390 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NCT04925856 ·Status: RECRUITING ·Phase: NA
-
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
NCT03580837 ·Status: UNKNOWN
-
Elevate! : An Elderly Breast Cancer Cohort Study
NCT03818087 ·Status: ACTIVE_NOT_RECRUITING
-
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
NCT04273542 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
MR Characterisation/Localisation of Breast Cancer
NCT01567137 ·Status: COMPLETED
-
SENOVIE France - Therapeutic Mobility and Breast Cancer
NCT06503393 ·Status: COMPLETED
-
MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer
NCT00462696 ·Status: COMPLETED ·Phase: NA
-
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
NCT03801850 ·Status: COMPLETED ·Phase: NA
-
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
NCT03870802 ·Status: RECRUITING
-
Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy
NCT01513408 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING